References
- Castela E, Archier E, Devaux S, et al. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. J Eur Acad Dermatol Venereol. 2012;26:47–51
- Nieman LK. Consequences of systemic absorption of topical glucocorticoids. J Am Acad Dermatol. 2011;65:250–2
- Vestergaard P, Olsen ML, Paaske Johnsen S, et al. Corticosteroid use and risk of hip fracture: a population-based case–control study in Denmark. J Intern Med. 2003;254:486–93
- Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with systemic and topical corticosteroids. J Intern Med. 2005;257:374–84
- Cayir A, Kaya A, Davutoğlu S, et al. Cushing's syndrome due to topical steroid. West Indian Med J. 2013;62:104–5
- Haeck IM, Hamdy NA, Timmer-de Mik L, et al. Low bone mineral density in adult patients with moderate to severe atopic dermatitis. Br J Dermatol. 2009;161:1248–54
- Takahashi H, Tsuji H, Honma M, et al. Femoral head osteonecrosis after long-term topical corticosteroid treatment in a psoriasis patient. J Dermatol. 2012;39:887–8
- Millard TP, Antoniades L, Evans AV, et al. Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol. 2001;26:446–8